Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

COMPLETED
Treatment of IgG4-Related Disease With Revlimid and Rituximab
Description

Among persons with Immunoglobulin G subclass 4 Related Disease (IgG4)-related disease who have persistent or recurrent disease despite standard therapies, does combination therapy with rituximab and revlimid cause a sustained disease remission?